Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tissue microRNA expression profiling in hepatic and pulmonary metastatic melanoma.
DiVincenzo MJ, Latchana N, Abrams Z, Moufawad M, Regan-Fendt K, Courtney NB, Howard JH, Gru AA, Zhang X, Fadda P, Carson WE. DiVincenzo MJ, et al. Among authors: latchana n. Melanoma Res. 2020 Oct;30(5):455-464. doi: 10.1097/CMR.0000000000000692. Melanoma Res. 2020. PMID: 32804708 Free PMC article.
Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
Latchana N, Del Campo SE, Grignol VP, Clark JR, Albert SP, Zhang J, Wei L, Aldrink JH, Nicol KK, Ranalli MA, Peters SB, Gru A, Trihka P, Payne PR, Howard JH, Carson WE 3rd. Latchana N, et al. Ann Surg Oncol. 2017 Feb;24(2):347-354. doi: 10.1245/s10434-016-5476-9. Epub 2016 Jul 28. Ann Surg Oncol. 2017. PMID: 27469124
MicroRNA dysregulation in melanoma.
Latchana N, Ganju A, Howard JH, Carson WE 3rd. Latchana N, et al. Surg Oncol. 2016 Sep;25(3):184-9. doi: 10.1016/j.suronc.2016.05.017. Epub 2016 May 20. Surg Oncol. 2016. PMID: 27566021 Review.
Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.
Latchana N, Regan K, Howard JH, Aldrink JH, Ranalli MA, Peters SB, Zhang X, Gru A, Payne PRO, Suarez-Kelly LP, Carson WE 3rd. Latchana N, et al. J Surg Res. 2016 Oct;205(2):350-358. doi: 10.1016/j.jss.2016.06.085. Epub 2016 Jul 4. J Surg Res. 2016. PMID: 27664883 Free PMC article.
Plasma MicroRNA Levels Following Resection of Metastatic Melanoma.
Latchana N, Abrams ZB, Howard JH, Regan K, Jacob N, Fadda P, Terando A, Markowitz J, Agnese D, Payne P, Carson WE 3rd. Latchana N, et al. Bioinform Biol Insights. 2017 Feb 23;11:1177932217694837. doi: 10.1177/1177932217694837. eCollection 2017. Bioinform Biol Insights. 2017. PMID: 28469417 Free PMC article.
Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy.
Duggan MC, Regan-Fendt K, Olaverria Salavaggione GN, Howard JH, Stiff AR, Sabella J, Latchana N, Markowitz J, Gru A, Tridandapani S, Eisfeld AK, de la Chapelle A, Carson WE. Duggan MC, et al. Among authors: latchana n. Melanoma Res. 2019 Oct;29(5):491-500. doi: 10.1097/CMR.0000000000000623. Melanoma Res. 2019. PMID: 31116161 Free PMC article.
MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
Martin del Campo SE, Latchana N, Levine KM, Grignol VP, Fairchild ET, Jaime-Ramirez AC, Dao TV, Karpa VI, Carson M, Ganju A, Chan AN, Carson WE 3rd. Martin del Campo SE, et al. Among authors: latchana n. PLoS One. 2015 Jan 14;10(1):e0115919. doi: 10.1371/journal.pone.0115919. eCollection 2015. PLoS One. 2015. PMID: 25587717 Free PMC article.
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches.
Markowitz J, Abrams Z, Jacob NK, Zhang X, Hassani JN, Latchana N, Wei L, Regan KE, Brooks TR, Uppati SR, Levine KM, Bekaii-Saab T, Kendra KL, Lesinski GB, Howard JH, Olencki T, Payne PR, Carson WE 3rd. Markowitz J, et al. Among authors: latchana n. Onco Targets Ther. 2016 Sep 29;9:5931-5941. doi: 10.2147/OTT.S106288. eCollection 2016. Onco Targets Ther. 2016. PMID: 27729802 Free PMC article.
Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma.
Duggan MC, Stiff AR, Bainazar M, Regan K, Olaverria Salavaggione GN, Maharry S, Blachly JS, Krischak M, Walker CJ, Latchana N, Tridandapani S, de la Chapelle A, Eisfeld AK, Carson WE 3rd. Duggan MC, et al. Among authors: latchana n. Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):9629-9634. doi: 10.1073/pnas.1704371114. Epub 2017 Aug 21. Proc Natl Acad Sci U S A. 2017. PMID: 28827320 Free PMC article.
29 results